pH-Sensitive mucoadhesive film-forming gels and wax-film composites suitable for topical and mucosal delivery of molecules

• US 7,803,392 B2
• Filed: 12/27/2000
• Issued: 09/28/2010
• Est. Priority Date: 12/27/2000
• Status: Expired due to Fees

• Current Assignee: University Of Kentucky Research Foundation (University of Kentucky)
• Original Assignee: University Of Kentucky Research Foundation (University of Kentucky)
• Inventors: Jay, Michael, Mumper, Russell
• Primary Examiner(s): Azpuru; Carlos A
• Application Number:
  US09/748,133
• Publication Number:
  US 20020142042A1
• Time in Patent Office: 3,562 Days
• Field of Search: 424/428, 424/484, 424/426, 424/28.04, 424/9.52, 424/430, 424/434, 424/435, 424/443
• US Class Current: 424/423
• CPC Class Codes: A61K 9/006 Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
• CPC Class Codes: A61K 9/06 Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels composition of ointments, creams or gels A61K47/00
• CPC Class Codes: A61K 9/70 Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug hollow drug-filled fibres A61K9/0092

Abstract

The present invention relates to pH-sensitive mucoadhesive film-forming gels and wax-film composites suitable for topical and mucosal delivery of molecules of interest, namely active pharmaceuticals. The gels comprise a pharmaceutically acceptable pH-sensitive polymer that responds to a lowering of pH by precipitating into films when in contact with the skin or mucosal surface. The films also comprise an adhesive polymer that allows the film to remain in contact with the tissue for an extended period of time. The wax-film composites comprise a bi-layer film having both the said pH-sensitive mucoadhesive layer to promote strong adherence to the skin and mucosal surfaces as well as a specially bonded wax layer intended to extend the adherence of the film to tissues for a prolonged period of time. The invention also relates to the use of said pH-sensitive film-forming gels and wax-film composites to deliver molecules of interest, such as small molecules, peptides, proteins, and nucleic acids either locally to act at the site of administration or for the absorption of said molecules of interest across biological membranes into the systemic circulation.

Claims

1. A pharmaceutical gel comprising:

a solvent vehicle comprising 25 to 100 parts by weight water or buffered water and 0 to 75 parts by weight of ethanol, propylene glycol, glycerin, polyethylene glycol, or combinations thereof, where the solvent vehicle is 100 parts by weight total;

at least one water-insoluble swellable mucoadhesive polymer, wherein the water-insoluble swellable mucoadhesive polymer is crossed-linked polyacrylic acid;

at least one pH-sensitive anionic copolymer of methacrylic acid and methacrylic acid esters, which forms a film when applied to skin or a mucosal surface, and

at least one molecule of interest.

2. The composition of claim 1, wherein the water-insoluble swellable mucoadhesive polymer is polyacrylic acid cross-linked with polyalkenyl ether or divinyl glycol.

3. The composition of claim 1, wherein the water-insoluble swellable mucoadhesive polymer is NOVEON or CARBOMER.

4. The composition of claim 1, wherein the water-insoluble swellable mucoadhesive polymer is present at a concentration of from 0.1% to 20% by weight.

5. The composition of claim 1, wherein the pH-sensitive polymer is present at a concentration of from 0.05% to 10% by weight.

6. The composition of claim 1, wherein the pH-sensitive polymer is a EUDRAGIT polymer.

7. The composition of claim 1, wherein the molecule of interest comprises an active pharmaceutical.

8. The composition of claim 1, wherein the molecule of interest is amlexanox.

9. The composition of claim 1, wherein the molecule of interest is triclosan.

10. The composition of claim 1, wherein the molecule of interest is hirudin.

11. The composition of claim 1, wherein the molecule of interest is plasmid DNA.

12. The composition of claim 1, wherein the molecule of interest is lidocaine, benzocaine, or dyclonine.

13. The composition of claim 1, wherein the molecule of interest is at least one benzodiazepine drug.

14. The gel of claim 1, wherein the molecule of interest is a peptide or protein.

15. The gel of claim 7, wherein the active pharmaceutical comprises an antimicrobial, antiviral, antiinflammatory, antiseptic, antihistamine, a local anesthetic, a disinfectant, a keratolytic, an analgesic, an anti-migraine, an anti-fungal, a sweetener, a flavoring agent, a diagnostic agent, or combination thereof.